-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Central Media Focus | 2025: Toward the New and the Future—The New Engine: Unleashing Momentum for Innovative Development
Category:
发布时间：2025-01-17
【概要描述】
Since the beginning of 2025, nearly half a month has passed, during which various regions and departments have formulated new strategies and implemented concrete measures. Across all sectors, proactive efforts are being made to embrace innovation and pursue new opportunities, with tailored approaches to developing new-quality productive forces and unleashing fresh momentum for growth. By leveraging innovation to drive development and capitalizing on distinctive strengths to capture market share, a robust wave of new-quality productivity is steadily gaining traction, painting a new picture of China’s economy.
Since the beginning of 2025, nearly half a month ago, governments and departments across the country have been devising new strategies and implementing concrete measures. All sectors have taken proactive steps to embrace innovation and pursue new opportunities, developing new-quality productive forces tailored to local conditions and unleashing fresh momentum for growth. By leveraging innovation to drive development and capitalizing on distinctive strengths to capture market share, a robust surge in the development of new-quality productive forces continues to unfold, painting a new picture of China’s economy.
Accelerated integration of scientific and technological innovation with industry is unlocking new potential for innovative development.
Turning “key variable” science and technology innovation into the “largest increment” for high-quality development hinges on achieving deep integration between scientific and technological innovation and industry. At Shijiazhuang Sihua Pharmaceutical Group in Hebei Province, the research and development of a new drug for kidney disease has made significant progress and is currently in the preclinical stage. Thanks to the robust support provided by a virtual screening and AI-driven drug discovery platform, the company’s innovative achievements are being accelerated into practical applications.
(Reprinted from Xinhua News Agency)
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091